▶ 調査レポート

次世代がん診断装置の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Next Generation Cancer Diagnostic Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。次世代がん診断装置の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Next Generation Cancer Diagnostic Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-11171資料のイメージです。• レポートコード:D005-11171
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、130ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥361,920 (USD3,480)▷ お問い合わせ
  Multi User¥542,880 (USD5,220)▷ お問い合わせ
  Corporate User¥723,840 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、次世代がん診断装置の世界市場を広く調査・分析し、今後の市場展望をまとめております。次世代がん診断装置の種類別市場規模(次世代シーケンシング、qPCR&マルチプレックス、Lab-on- a-chip(LOAC)、タンパク質マイクロアレイ、DNAマイクロアレイ、逆転写酵素-PCR(RT-PCR))、用途別市場規模(バイオマーカー開発、CTC分析、プロテオミクス分析、エピジェネティック分析、遺伝子分析)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Roche Holding Ltd.(Switzerland)、Affymetrix Inc.(US)、Agilent Technologies Inc(Germany)、Abbott Laboratories(US)、QIAGEN N.V.(Germany)、Siemens Healthcare(Germany)、Thermo Fisher Scientific Inc.(US)、Becton Dickinson and Co.(US)、Illumina Inc.(US)、Johnson & Johnson(US)、Allegro Diagnostics Corp.(Brazil)、GE Healthcare(England)、Cepheid Inc.(US)、Life Technologies Corp.(US)、Luminex Corp.(US)
・地域別グローバル市場分析 2015年-2020年
・次世代がん診断装置の北米市場(アメリカ、カナダ、メキシコ)
・次世代がん診断装置のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・次世代がん診断装置のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・次世代がん診断装置の南米市場(ブラジル、アルゼンチン)
・次世代がん診断装置の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:次世代シーケンシング、qPCR&マルチプレックス、Lab-on- a-chip(LOAC)、タンパク質マイクロアレイ、DNAマイクロアレイ、逆転写酵素-PCR(RT-PCR)
・用途別分析:バイオマーカー開発、CTC分析、プロテオミクス分析、エピジェネティック分析、遺伝子分析
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Next Generation Cancer Diagnostic Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Next Generation Cancer Diagnostic Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Next Generation Cancer Diagnostic Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Next Generation Cancer Diagnostic Devices market has been segmented into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)

By Application, Next Generation Cancer Diagnostic Devices has been segmented into:
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Next Generation Cancer Diagnostic Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Next Generation Cancer Diagnostic Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Next Generation Cancer Diagnostic Devices market.

The report offers in-depth assessment of the growth and other aspects of the Next Generation Cancer Diagnostic Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Next Generation Cancer Diagnostic Devices Market Share Analysis
Next Generation Cancer Diagnostic Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Next Generation Cancer Diagnostic Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Next Generation Cancer Diagnostic Devices sales, revenue and market share for each player covered in this report.

The major players covered in Next Generation Cancer Diagnostic Devices are:
Roche Holding Ltd.(Switzerland)
Affymetrix Inc.(US)
Agilent Technologies Inc(Germany)
Abbott Laboratories(US)
QIAGEN N.V.(Germany)
Siemens Healthcare(Germany)
Thermo Fisher Scientific Inc.(US)
Becton Dickinson and Co.(US)
Illumina Inc.(US)
Johnson & Johnson(US)
Allegro Diagnostics Corp.(Brazil)
GE Healthcare(England)
Cepheid Inc.(US)
Life Technologies Corp.(US)
Luminex Corp.(US)

Among other players domestic and global, Next Generation Cancer Diagnostic Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Next Generation Cancer Diagnostic Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Next Generation Cancer Diagnostic Devices, with price, sales, revenue and global market share of Next Generation Cancer Diagnostic Devices in 2018 and 2019.
Chapter 3, the Next Generation Cancer Diagnostic Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Next Generation Cancer Diagnostic Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Next Generation Cancer Diagnostic Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Next Generation Cancer Diagnostic Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Next Generation Cancer Diagnostic Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Next Generation Cancer Diagnostic Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.2.7 Reverse Transcriptase-PCR (RT-PCR)
1.3 Market Analysis by Application
1.3.1 Overview: Global Next Generation Cancer Diagnostic Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Overview of Global Next Generation Cancer Diagnostic Devices Market
1.4.1 Global Next Generation Cancer Diagnostic Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche Holding Ltd.(Switzerland)
2.1.1 Roche Holding Ltd.(Switzerland) Details
2.1.2 Roche Holding Ltd.(Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche Holding Ltd.(Switzerland) SWOT Analysis
2.1.4 Roche Holding Ltd.(Switzerland) Product and Services
2.1.5 Roche Holding Ltd.(Switzerland) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Affymetrix Inc.(US)
2.2.1 Affymetrix Inc.(US) Details
2.2.2 Affymetrix Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Affymetrix Inc.(US) SWOT Analysis
2.2.4 Affymetrix Inc.(US) Product and Services
2.2.5 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Agilent Technologies Inc(Germany)
2.3.1 Agilent Technologies Inc(Germany) Details
2.3.2 Agilent Technologies Inc(Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Agilent Technologies Inc(Germany) SWOT Analysis
2.3.4 Agilent Technologies Inc(Germany) Product and Services
2.3.5 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott Laboratories(US)
2.4.1 Abbott Laboratories(US) Details
2.4.2 Abbott Laboratories(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott Laboratories(US) SWOT Analysis
2.4.4 Abbott Laboratories(US) Product and Services
2.4.5 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 QIAGEN N.V.(Germany)
2.5.1 QIAGEN N.V.(Germany) Details
2.5.2 QIAGEN N.V.(Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 QIAGEN N.V.(Germany) SWOT Analysis
2.5.4 QIAGEN N.V.(Germany) Product and Services
2.5.5 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Siemens Healthcare(Germany)
2.6.1 Siemens Healthcare(Germany) Details
2.6.2 Siemens Healthcare(Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Siemens Healthcare(Germany) SWOT Analysis
2.6.4 Siemens Healthcare(Germany) Product and Services
2.6.5 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Thermo Fisher Scientific Inc.(US)
2.7.1 Thermo Fisher Scientific Inc.(US) Details
2.7.2 Thermo Fisher Scientific Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Thermo Fisher Scientific Inc.(US) SWOT Analysis
2.7.4 Thermo Fisher Scientific Inc.(US) Product and Services
2.7.5 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Becton Dickinson and Co.(US)
2.8.1 Becton Dickinson and Co.(US) Details
2.8.2 Becton Dickinson and Co.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Becton Dickinson and Co.(US) SWOT Analysis
2.8.4 Becton Dickinson and Co.(US) Product and Services
2.8.5 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Illumina Inc.(US)
2.9.1 Illumina Inc.(US) Details
2.9.2 Illumina Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Illumina Inc.(US) SWOT Analysis
2.9.4 Illumina Inc.(US) Product and Services
2.9.5 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Johnson & Johnson(US)
2.10.1 Johnson & Johnson(US) Details
2.10.2 Johnson & Johnson(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Johnson & Johnson(US) SWOT Analysis
2.10.4 Johnson & Johnson(US) Product and Services
2.10.5 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Allegro Diagnostics Corp.(Brazil)
2.11.1 Allegro Diagnostics Corp.(Brazil) Details
2.11.2 Allegro Diagnostics Corp.(Brazil) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Allegro Diagnostics Corp.(Brazil) SWOT Analysis
2.11.4 Allegro Diagnostics Corp.(Brazil) Product and Services
2.11.5 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 GE Healthcare(England)
2.12.1 GE Healthcare(England) Details
2.12.2 GE Healthcare(England) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 GE Healthcare(England) SWOT Analysis
2.12.4 GE Healthcare(England) Product and Services
2.12.5 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Cepheid Inc.(US)
2.13.1 Cepheid Inc.(US) Details
2.13.2 Cepheid Inc.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Cepheid Inc.(US) SWOT Analysis
2.13.4 Cepheid Inc.(US) Product and Services
2.13.5 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Life Technologies Corp.(US)
2.14.1 Life Technologies Corp.(US) Details
2.14.2 Life Technologies Corp.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Life Technologies Corp.(US) SWOT Analysis
2.14.4 Life Technologies Corp.(US) Product and Services
2.14.5 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Luminex Corp.(US)
2.15.1 Luminex Corp.(US) Details
2.15.2 Luminex Corp.(US) Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Luminex Corp.(US) SWOT Analysis
2.15.4 Luminex Corp.(US) Product and Services
2.15.5 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Next Generation Cancer Diagnostic Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Next Generation Cancer Diagnostic Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Next Generation Cancer Diagnostic Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
4.3 Europe Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
4.5 South America Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Next Generation Cancer Diagnostic Devices Sales, Revenue and Market Share by Country
5.1.1 North America Next Generation Cancer Diagnostic Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Next Generation Cancer Diagnostic Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
5.3 Canada Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Next Generation Cancer Diagnostic Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Next Generation Cancer Diagnostic Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Next Generation Cancer Diagnostic Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
6.3 UK Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
6.4 France Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
6.5 Russia Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
6.6 Italy Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Next Generation Cancer Diagnostic Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Next Generation Cancer Diagnostic Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
7.3 Japan Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
7.4 Korea Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
7.5 India Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
7.7 Australia Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Next Generation Cancer Diagnostic Devices Sales, Revenue and Market Share by Country
8.1.1 South America Next Generation Cancer Diagnostic Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Next Generation Cancer Diagnostic Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Next Generation Cancer Diagnostic Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Type (2015-2020)
10.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2015-2020)
11 Global Next Generation Cancer Diagnostic Devices Market Segment by Application
11.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
11.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2015-2020)
11.3 Global Next Generation Cancer Diagnostic Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Next Generation Cancer Diagnostic Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Next Generation Cancer Diagnostic Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025)
12.2.2 Europe Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025)
12.2.4 South America Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025)
12.3 Next Generation Cancer Diagnostic Devices Market Forecast by Type (2021-2025)
12.3.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Type (2021-2025)
12.4 Next Generation Cancer Diagnostic Devices Market Forecast by Application (2021-2025)
12.4.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Next Generation Cancer Diagnostic Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Next Generation Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Next Generation Cancer Diagnostic Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Roche Holding Ltd.(Switzerland) Basic Information, Manufacturing Base and Competitors
Table 8. Roche Holding Ltd.(Switzerland) Next Generation Cancer Diagnostic Devices Major Business
Table 9. Roche Holding Ltd.(Switzerland) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 10. Roche Holding Ltd.(Switzerland) SWOT Analysis
Table 11. Roche Holding Ltd.(Switzerland) Next Generation Cancer Diagnostic Devices Product and Services
Table 12. Roche Holding Ltd.(Switzerland) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Affymetrix Inc.(US) Basic Information, Manufacturing Base and Competitors
Table 14. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Major Business
Table 15. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 16. Affymetrix Inc.(US) SWOT Analysis
Table 17. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 18. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Agilent Technologies Inc(Germany) Basic Information, Manufacturing Base and Competitors
Table 20. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Major Business
Table 21. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 22. Agilent Technologies Inc(Germany) SWOT Analysis
Table 23. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product and Services
Table 24. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Abbott Laboratories(US) Basic Information, Manufacturing Base and Competitors
Table 26. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Major Business
Table 27. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 28. Abbott Laboratories(US) SWOT Analysis
Table 29. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 30. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. QIAGEN N.V.(Germany) Basic Information, Manufacturing Base and Competitors
Table 32. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Major Business
Table 33. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 34. QIAGEN N.V.(Germany) SWOT Analysis
Table 35. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product and Services
Table 36. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Siemens Healthcare(Germany) Basic Information, Manufacturing Base and Competitors
Table 38. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Major Business
Table 39. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 40. Siemens Healthcare(Germany) SWOT Analysis
Table 41. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product and Services
Table 42. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Thermo Fisher Scientific Inc.(US) Basic Information, Manufacturing Base and Competitors
Table 44. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Major Business
Table 45. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 46. Thermo Fisher Scientific Inc.(US) SWOT Analysis
Table 47. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 48. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Becton Dickinson and Co.(US) Basic Information, Manufacturing Base and Competitors
Table 50. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Major Business
Table 51. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 52. Becton Dickinson and Co.(US) SWOT Analysis
Table 53. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 54. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Illumina Inc.(US) Basic Information, Manufacturing Base and Competitors
Table 56. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Major Business
Table 57. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 58. Illumina Inc.(US) SWOT Analysis
Table 59. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 60. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Johnson & Johnson(US) Basic Information, Manufacturing Base and Competitors
Table 62. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Major Business
Table 63. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 64. Johnson & Johnson(US) SWOT Analysis
Table 65. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 66. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Allegro Diagnostics Corp.(Brazil) Basic Information, Manufacturing Base and Competitors
Table 68. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Major Business
Table 69. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 70. Allegro Diagnostics Corp.(Brazil) SWOT Analysis
Table 71. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product and Services
Table 72. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. GE Healthcare(England) Basic Information, Manufacturing Base and Competitors
Table 74. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Major Business
Table 75. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 76. GE Healthcare(England) SWOT Analysis
Table 77. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product and Services
Table 78. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Cepheid Inc.(US) Basic Information, Manufacturing Base and Competitors
Table 80. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Major Business
Table 81. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 82. Cepheid Inc.(US) SWOT Analysis
Table 83. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 84. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Life Technologies Corp.(US) Basic Information, Manufacturing Base and Competitors
Table 86. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Major Business
Table 87. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 88. Life Technologies Corp.(US) SWOT Analysis
Table 89. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 90. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Luminex Corp.(US) Basic Information, Manufacturing Base and Competitors
Table 92. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Major Business
Table 93. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Total Revenue (USD Million) (2018-2019)
Table 94. Luminex Corp.(US) SWOT Analysis
Table 95. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product and Services
Table 96. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Next Generation Cancer Diagnostic Devices Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Next Generation Cancer Diagnostic Devices Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Regions (2015-2020)
Table 101. Global Next Generation Cancer Diagnostic Devices Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Next Generation Cancer Diagnostic Devices Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2015-2020)
Table 104. North America Next Generation Cancer Diagnostic Devices Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2015-2020)
Table 106. Europe Next Generation Cancer Diagnostic Devices Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2015-2020)
Table 108. Europe Next Generation Cancer Diagnostic Devices Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Next Generation Cancer Diagnostic Devices Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2015-2020)
Table 114. South America Next Generation Cancer Diagnostic Devices Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2015-2020)
Table 120. Global Next Generation Cancer Diagnostic Devices Sales by Type (2015-2020) (K Pcs)
Table 121. Global Next Generation Cancer Diagnostic Devices Sales Share by Type (2015-2020)
Table 122. Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020) (USD Million)
Table 123. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2015-2020)
Table 124. Global Next Generation Cancer Diagnostic Devices Sales by Application (2015-2020) (K Pcs)
Table 125. Global Next Generation Cancer Diagnostic Devices Sales Share by Application (2015-2020)
Table 126. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Regions (2021-2025)
Table 128. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Type (2021-2025)
Table 130. Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2021-2025)
Table 131. Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Next Generation Cancer Diagnostic Devices Picture
Figure 2. Global Sales Market Share of Next Generation Cancer Diagnostic Devices by Type in 2019
Figure 3. Next Generation Sequencing Picture
Figure 4. qPCR & Multiplexing Picture
Figure 5. Lab-on- a- chip (LOAC) Picture
Figure 6. Protein Microarrays Picture
Figure 7. DNA Microarrays Picture
Figure 8. Reverse Transcriptase-PCR (RT-PCR) Picture
Figure 9. Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2018
Figure 10. Biomarker Development Picture
Figure 11. CTC Analysis Picture
Figure 12. Proteomic Analysis Picture
Figure 13. Epigenetic Analysis Picture
Figure 14. Genetic Analysis Picture
Figure 15. Global Next Generation Cancer Diagnostic Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Next Generation Cancer Diagnostic Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturer in 2019
Figure 36. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Next Generation Cancer Diagnostic Devices Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Next Generation Cancer Diagnostic Devices Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 41. Global Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions (2015-2020)
Figure 43. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions in 2018
Figure 44. North America Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
Figure 45. Europe Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
Figure 47. South America Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020)
Figure 49. North America Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries (2015-2020)
Figure 51. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries in 2018
Figure 52. North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries in 2018
Figure 54. United States Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Canada Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Mexico Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Europe Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries in 2019
Figure 60. Germany Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. UK Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. France Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Italy Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions 2019
Figure 68. China Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Korea Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. India Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Southeast Asia Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. South America Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Next Generation Cancer Diagnostic Devices Sales Market Share by Countries in 2019
Figure 75. South America Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries in 2019
Figure 76. Brazil Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Argentina Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Next Generation Cancer Diagnostic Devices Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Egypt Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Turkey Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. South Africa Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Global Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2021-2025) (K Pcs)
Figure 87. Global Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025) (K Pcs)
Figure 89. Europe Sales Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025) (K Pcs)
Figure 90. Asia-Pacific Sales Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025) (K Pcs)
Figure 91. South America Sales Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025) (K Pcs)
Figure 92. Middle East & Africa Sales Next Generation Cancer Diagnostic Devices Market Forecast (2021-2025) (K Pcs)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel